Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)

v3.21.2
Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Disaggregation of Revenue [Line Items]        
Total revenue $ 64,835 $ 41,848 $ 204,660 $ 116,429
Royalties        
Disaggregation of Revenue [Line Items]        
Total revenue 15,648 9,005 31,376 22,751
Kyprolis        
Disaggregation of Revenue [Line Items]        
Total revenue 8,821 6,923 18,548 16,809
Evomela        
Disaggregation of Revenue [Line Items]        
Total revenue 2,665 1,802 7,191 4,577
Other        
Disaggregation of Revenue [Line Items]        
Total revenue 4,162 280 5,637 1,365
Captisol        
Disaggregation of Revenue [Line Items]        
Total revenue 35,093 23,389 128,875 68,966
Contract revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 14,094 9,454 44,409 24,712
Service Revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 4,828 7,341 17,650 15,280
License Fees        
Disaggregation of Revenue [Line Items]        
Total revenue 200 158 2,293 1,793
Milestone        
Disaggregation of Revenue [Line Items]        
Total revenue 7,419 960 19,436 4,766
Other        
Disaggregation of Revenue [Line Items]        
Total revenue $ 1,647 $ 995 $ 5,030 $ 2,873